To sign up for Analytiqa's free weekly newsletter, please enter your details below.
Analytiqa will not share this information with third parties.
Cryoport to provide Nohla Therapeutics with cold chain logistics 02 October 2017
Transporting cryogenically preserved commodities for clinical trials
Cryoport will provide its cold chain logistics solutions to support Nohla Therapeutics' clinical studies evaluating its universal donor cell therapy, NLA101, in patients with hematologic malignancies and other critical diseases.
As a part of the agreement, Cryoport will provide global logistics support for Nohla's Phase 2 clinical trials, observing international best practices for transporting cryogenically preserved commodities.
Cryoport's suite of unique cryogenic logistics solutions includes its Cryoport Express shippers, SmartPak II Condition Monitoring System, Cryoportal Logistics Management Platform and 24/7/365 logistics support.
These unparalleled capabilities enable Nohla to monitor its shipments and track the conditions and location of its biological commodities in transit around the clock, and to deploy intervention capability to mitigate any potential logistics risks.